These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
973 related items for PubMed ID: 24994869
21. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment. Jirsova K, Brejchova K, Krabcova I, Filipec M, Al Fakih A, Palos M, Vesela V. Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049 [Abstract] [Full Text] [Related]
22. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops. Safarzadeh M, Azizzadeh P, Akbarshahi P. J Optom; 2017 Jan; 10(4):258-264. PubMed ID: 27989693 [Abstract] [Full Text] [Related]
23. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. Kojima T, Ishida R, Dogru M, Goto E, Matsumoto Y, Kaido M, Tsubota K. Am J Ophthalmol; 2005 Feb; 139(2):242-6. PubMed ID: 15733983 [Abstract] [Full Text] [Related]
24. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Labbé A, Terry O, Brasnu E, Van Went C, Baudouin C. Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490 [Abstract] [Full Text] [Related]
25. Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eye. Jacobi C, Kruse FE, Cursiefen C. J Ocul Pharmacol Ther; 2012 Dec; 28(6):598-603. PubMed ID: 22813209 [Abstract] [Full Text] [Related]
27. OCT assessment of tear meniscus after punctal occlusion in dry eye disease. Ibrahim OM, Dogru M, Kojima T, Matsumoto Y, Wakamatsu TH, Tsubota K, Fujishima H. Optom Vis Sci; 2012 May; 89(5):E770-6. PubMed ID: 22466101 [Abstract] [Full Text] [Related]
29. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye. Shimazaki-Den S, Iseda H, Dogru M, Shimazaki J. Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860 [Abstract] [Full Text] [Related]
30. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Toker E, Asfuroğlu E. Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564 [Abstract] [Full Text] [Related]
31. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops. Macri A, Scanarotti C, Bassi AM, Giuffrida S, Sangalli G, Traverso CE, Iester M. Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):425-30. PubMed ID: 25398660 [Abstract] [Full Text] [Related]
32. Comparative analysis of carmellose 0.5% versus hyaluronate 0.15% in dry eye: a flow cytometric study. Sanchez MA, Torralbo-Jimenez P, Giron N, de la Heras B, Herrero Vanrell R, Arriola-Villalobos P, Diaz-Valle D, Alvarez-Barrientos A, Benitez-Del-Castillo JM. Cornea; 2010 Feb; 29(2):167-71. PubMed ID: 20023577 [Abstract] [Full Text] [Related]
33. Comparison of 0.3% Hypotonic and Isotonic Sodium Hyaluronate Eye Drops in the Treatment of Experimental Dry Eye. Li Y, Cui L, Lee HS, Kang YS, Choi W, Yoon KC. Curr Eye Res; 2017 Aug; 42(8):1108-1114. PubMed ID: 28441078 [Abstract] [Full Text] [Related]
34. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients. Lee SY, Han SJ, Nam SM, Yoon SC, Ahn JM, Kim TI, Kim EK, Seo KY. Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063 [Abstract] [Full Text] [Related]
35. Effects of the preoperative use of artificial tears combined with recombinant bovine basic fibroblast growth factor on cataract patients complicated with dry eyes. Xiao W, Huang P. Arq Bras Oftalmol; 2022 Aug; 87(2):0539. PubMed ID: 36169441 [Abstract] [Full Text] [Related]
36. Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease. Hussain M, Shtein RM, Sugar A, Soong HK, Woodward MA, DeLoss K, Mian SI. Cornea; 2014 Dec; 33(12):1245-51. PubMed ID: 25299423 [Abstract] [Full Text] [Related]
37. Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers. Manni G, Centofanti M, Oddone F, Parravano M, Bucci MG. Am J Ophthalmol; 2005 Jan; 139(1):72-7. PubMed ID: 15652830 [Abstract] [Full Text] [Related]
38. Comparative role of 20% cord blood serum and 20% autologous serum in dry eye associated with Hansen's disease: a tear proteomic study. Mukhopadhyay S, Sen S, Datta H. Br J Ophthalmol; 2015 Jan; 99(1):108-12. PubMed ID: 25138758 [Abstract] [Full Text] [Related]
39. Immunomodulatory effect of the topical ophthalmic Janus kinase inhibitor tofacitinib (CP-690,550) in patients with dry eye disease. Huang JF, Yafawi R, Zhang M, McDowell M, Rittenhouse KD, Sace F, Liew SH, Cooper SR, Pickering EH. Ophthalmology; 2012 Jul; 119(7):e43-50. PubMed ID: 22607938 [Abstract] [Full Text] [Related]
40. Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye. Aragona P, Papa V, Micali A, Santocono M, Milazzo G. Br J Ophthalmol; 2002 Feb; 86(2):181-4. PubMed ID: 11815344 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]